BioPharma
Algeria Showcases its Strength in African Pharma Sector
Abdelmadjid Tebboune, the Algerian president, went on to address participants at the African Ministerial Conference on Local Pharmaceutical Production and Health Technologies on November 27,...
News
The Future of Health and Wellbeing: A Market on the Rise
The health and wellbeing market has experienced significant growth over the past decade, driven by an increasing awareness of physical and mental health issues. As...
News
Synthetic Drugs: A Growing Crisis or Signs of Improvement?
The landscape of drug usage has undergone significant changes in recent years, particularly with the rise of synthetic drugs. These substances, often engineered to mimic...
BioPharma
Eli Lilly Becomes the First Drugmaker to Hit $1tn Valuation
Eli Lilly, the US pharma giant, has become the first drugmaker to hit $1tn valuation on November 22, 2025, hence entering the exclusive club, which...
Business & Industry
400 Global Regulatory Manufacturing Approvals for Samsung Biologics
Samsung Biologics announced on November 26, 2025, that it has gone on to achieve a whopping 400 regulatory manufacturing approvals all over the world due to its...
News
Clinical Trial Services and the Role of a European CRO
Conducting a clinical trial today requires coordinated procedures, standardized documentation, and a clear understanding of the regulatory systems that govern research. As more studies extend...
Business & Industry
AstraZeneca, Biopharma Giant, Announces $2bn Investment in Maryland
It should not be termed as an overstatement when we say that Maryland is fast becoming the home away from home when it comes to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.















